Save
Email
Print
Share
RSSBrowse News Stories
21 to 30 of 317 stories
view headlines only
-
Scientists Seek out Cancer Cells Hiding from Treatment
January 16, 2013 — Funding to improve leukemia treatment will investigate how cancer cells hide to avoid chemotherapy ... > full story -
Epigenomic Abnormalities Predict Patient Survival in Non-Hodgkins Lymphoma
January 10, 2013 — "Not only do we see more abnormal methylation in non-Hodgkin lymphoma patients than in healthy B-cell populations, but there are three distinct subtypes of the disease in the clinic, each more ... > full story -
Cellular Fuel Gauge May Hold the Key to Restricting Cancer Growth
December 27, 2012 — Researchers have discovered that a key regulator of energy metabolism in cancer cells known as the AMP-activated protein kinase (AMPK) may play a crucial role in restricting cancer cell growth. AMPK ... > full story -
New Technique Catalogs Lymphoma-Linked Genetic Variations
December 26, 2012 — As anyone familiar with the X-Men knows, mutants can be either very good or very bad — or somewhere in between. The same appears true within cancer cells, which may harbor hundreds of mutations ... > full story -
Cancer Diagnosis Later in Life Poses Significant Risk to Offspring, Study Suggests
December 20, 2012 — Relatives of family members diagnosed with cancer are still at risk of the disease even if the diagnosis came at an older age, a new paper ... > full story -
Ibrutinib Has 'Unprecedented' Impact on Mantle Cell Lymphoma
December 14, 2012 — An international study of ibrutinib in people with relapsed or refractory mantle cell lymphoma (MCL) continues to show unprecedented and durable results with few side ... > full story -
Hard-to-Treat Myc-Driven Cancers May Be Susceptible to Drug Already Used in Clinic
December 14, 2012 — Drugs that are used in the clinic to treat some forms of breast and kidney cancer and that work by inhibiting the signaling molecule mTORC1 might have utility in treating some of the more than 15 ... > full story -
Lymphoma
Diseases and Conditions
Today's Healthcare
Colon Cancer
Wounds and Healing
Multiple Sclerosis Research
Blood Levels of Immune Protein Predict Risk in Hodgkin Disease
December 10, 2012 — Researchers found levels galectin-1, an immunity-related protein, could be the basis of a test and potentially a targeted treatment for Hodgkin ... > full story -
Novel Drug Therapy Targets Aggressive Form of Non-Hodgkin's Lymphoma
December 10, 2012 — Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of non-Hodgkin's lymphoma and the seventh most frequently diagnosed cancer. The most chemotherapy resistant form of DLBCL, called ... > full story -
Pathway Identified in Human Lymphoma Points Way to New Blood Cancer Treatments
November 21, 2012 — Research, shows for the first time that the "unfolded protein response" is active in patients with human lymphomas and mice genetically bred to develop lymphomas. Importantly, when the UPR is ... > full story
Search ScienceDaily
Number of stories in archives: 140,690
more 
